calpain inhibitor 2 has been researched along with squalestatin 1 in 1 studies
| Studies (calpain inhibitor 2) | Trials (calpain inhibitor 2) | Recent Studies (post-2010) (calpain inhibitor 2) | Studies (squalestatin 1) | Trials (squalestatin 1) | Recent Studies (post-2010) (squalestatin 1) |
|---|---|---|---|---|---|
| 68 | 0 | 13 | 104 | 0 | 26 |
| Protein | Taxonomy | calpain inhibitor 2 (IC50) | squalestatin 1 (IC50) |
|---|---|---|---|
| Adenosine receptor A1 | Rattus norvegicus (Norway rat) | 0.0005 | |
| Protein farnesyltransferase subunit beta | Rattus norvegicus (Norway rat) | 0.012 | |
| Squalene synthase | Rattus norvegicus (Norway rat) | 0.0063 | |
| Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | Rattus norvegicus (Norway rat) | 0.012 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avner, R; Doolman, R; Harats, D; Ravid, T; Roitelman, J | 1 |
1 other study(ies) available for calpain inhibitor 2 and squalestatin 1
| Article | Year |
|---|---|
The ubiquitin-proteasome pathway mediates the regulated degradation of mammalian 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
Topics: Animals; beta-Galactosidase; Bridged Bicyclo Compounds, Heterocyclic; Cell Line; Cholesterol; Cricetinae; Cycloheximide; Cysteine Proteinase Inhibitors; Farnesyl-Diphosphate Farnesyltransferase; Humans; Hydroxycholesterols; Hydroxymethylglutaryl CoA Reductases; Leupeptins; Lovastatin; Oligopeptides; Peptide Hydrolases; Precipitin Tests; Proteasome Endopeptidase Complex; Recombinant Fusion Proteins; Tricarboxylic Acids; Ubiquitins | 2000 |